Additionally, the STAT3 (signal transducer and activator of transcription 3) signaling pathway, which is often highly active in glioma cells and contributes to drug resistance, was remarkably inhibited in Res/TMZ-treated GBM cells [243]. This evidence concerns the gene STAT3 and central nervous system cancer.